These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Duroquinone reduction during passage through the pulmonary circulation. Audi SH; Bongard RD; Dawson CA; Siegel D; Roerig DL; Merker MP Am J Physiol Lung Cell Mol Physiol; 2003 Nov; 285(5):L1116-31. PubMed ID: 12882764 [TBL] [Abstract][Full Text] [Related]
5. Role of mitochondrial electron transport complex I in coenzyme Q1 reduction by intact pulmonary arterial endothelial cells and the effect of hyperoxia. Merker MP; Audi SH; Lindemer BJ; Krenz GS; Bongard RD Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L809-19. PubMed ID: 17601793 [TBL] [Abstract][Full Text] [Related]
6. Genetic evidence for NAD(P)H:quinone oxidoreductase 1-catalyzed quinone reduction on passage through the mouse pulmonary circulation. Lindemer BJ; Bongard RD; Hoffmann R; Baumgardt S; Gonzalez FJ; Merker MP Am J Physiol Lung Cell Mol Physiol; 2011 May; 300(5):L773-80. PubMed ID: 21296895 [TBL] [Abstract][Full Text] [Related]
7. Coenzyme Q1 redox metabolism during passage through the rat pulmonary circulation and the effect of hyperoxia. Audi SH; Merker MP; Krenz GS; Ahuja T; Roerig DL; Bongard RD J Appl Physiol (1985); 2008 Oct; 105(4):1114-26. PubMed ID: 18703762 [TBL] [Abstract][Full Text] [Related]
8. Preferential utilization of NADPH as the endogenous electron donor for NAD(P)H:quinone oxidoreductase 1 (NQO1) in intact pulmonary arterial endothelial cells. Bongard RD; Lindemer BJ; Krenz GS; Merker MP Free Radic Biol Med; 2009 Jan; 46(1):25-32. PubMed ID: 18848878 [TBL] [Abstract][Full Text] [Related]
9. Coenzyme Q(1) as a probe for mitochondrial complex I activity in the intact perfused hyperoxia-exposed wild-type and Nqo1-null mouse lung. Bongard RD; Myers CR; Lindemer BJ; Baumgardt S; Gonzalez FJ; Merker MP Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L949-58. PubMed ID: 22268123 [TBL] [Abstract][Full Text] [Related]
10. Differential responses of targeted lung redox enzymes to rat exposure to 60 or 85% oxygen. Gan Z; Roerig DL; Clough AV; Audi SH J Appl Physiol (1985); 2011 Jul; 111(1):95-107. PubMed ID: 21551015 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the threshold for NAD(P)H:quinone oxidoreductase activity in intact sulforaphane-treated pulmonary arterial endothelial cells. Bongard RD; Krenz GS; Gastonguay AJ; Williams CL; Lindemer BJ; Merker MP Free Radic Biol Med; 2011 Apr; 50(8):953-62. PubMed ID: 21238579 [TBL] [Abstract][Full Text] [Related]
12. NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) and cytochrome P450 oxidoreductase (CYP450OR) differentially regulate menadione-mediated alterations in redox status, survival and metabolism in pancreatic β-cells. Gray JP; Karandrea S; Burgos DZ; Jaiswal AA; Heart EA Toxicol Lett; 2016 Nov; 262():1-11. PubMed ID: 27558805 [TBL] [Abstract][Full Text] [Related]
13. The contribution of vascular endothelial xanthine dehydrogenase/oxidase to oxygen-mediated cell injury. Panus PC; Wright SA; Chumley PH; Radi R; Freeman BA Arch Biochem Biophys; 1992 May; 294(2):695-702. PubMed ID: 1567225 [TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of the human NAD(P)H:quinone oxidoreductase (NQO1) gene by monofunctional inducers. Wang B; Williamson G Biochim Biophys Acta; 1996 Jun; 1307(1):104-10. PubMed ID: 8652659 [TBL] [Abstract][Full Text] [Related]
15. Depolarized mitochondrial membrane potential and protection with duroquinone in isolated perfused lungs from rats exposed to hyperoxia. Audi SH; Ganesh S; Taheri P; Zhang X; Dash RK; Clough AV; Jacobs ER J Appl Physiol (1985); 2022 Feb; 132(2):346-356. PubMed ID: 34941441 [TBL] [Abstract][Full Text] [Related]
16. The bioreduction of a series of benzoquinone ansamycins by NAD(P)H:quinone oxidoreductase 1 to more potent heat shock protein 90 inhibitors, the hydroquinone ansamycins. Guo W; Reigan P; Siegel D; Zirrolli J; Gustafson D; Ross D Mol Pharmacol; 2006 Oct; 70(4):1194-203. PubMed ID: 16825487 [TBL] [Abstract][Full Text] [Related]
17. Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition. Guo W; Reigan P; Siegel D; Zirrolli J; Gustafson D; Ross D Cancer Res; 2005 Nov; 65(21):10006-15. PubMed ID: 16267026 [TBL] [Abstract][Full Text] [Related]
18. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Siegel D; Gustafson DL; Dehn DL; Han JY; Boonchoong P; Berliner LJ; Ross D Mol Pharmacol; 2004 May; 65(5):1238-47. PubMed ID: 15102952 [TBL] [Abstract][Full Text] [Related]
19. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase. Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423 [TBL] [Abstract][Full Text] [Related]
20. Role of NAD(P)H:quinone oxidoreductase (NQO1) in apoptosis induction by aziridinylbenzoquinones RH1 and MeDZQ. Nemeikaite-Ceniene A; Dringeliene A; Sarlauskas J; Cenas N Acta Biochim Pol; 2005; 52(4):937-41. PubMed ID: 15940348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]